Navigation Links
JAZZ PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2013 FINANCIAL RESULTS
Date:5/7/2013

ingent consideration, non-current

-34,800Deferred tax liability, net, non-current

169,176178,393Other non-current liabilities

9,8176,621Total shareholders' equity

1,161,9001,121,292Total liabilities and shareholders' equity

$ 2,009,690$ 1,966,493JAZZ PHARMACEUTICALS PLCRECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES(In thousands, except per share amounts)(Unaudited)Three Months EndedMarch 31,20132012GAAP income from continuing operations

$
43,425$
30,235 Intangible asset amortization

19,55510,732 Share-based compensation expense

8,7573,281 Acquisition accounting inventory fair value step-up

1,5451,308 Transaction and integration costs

1,0226,095 Restructuring charges

949- Change in fair value of contingent consideration

4,500- Upfront license fees

4,000- Depreciation

575- Other non-cash expense 

1,22942 Income tax adjustments

(1,132)-Adjusted net income

$
84,425$
51,693GAAP income from continuing operations per diluted share

$
.71$
.52Adjusted net income per diluted share

$
.37$
.89Shares used in computing GAAP income from continuing operations and adjusted net income per diluted share amounts

61,51158,084  JAZZ PHARMACEUTICALS PLC  RECONCILIATION OF GAAP TO NON-GAAP ADJUSTED INFORMATION  CERTAIN LINE  ITEMS AND OTHER INFORMATION  (In thousands, except per share amounts and percentages)  (Unaudited) Three Months EndedMarch 31, 2013March 31, 2012GAAPAdjustmentNon-GAAPGAAPAdjustmentNon-GAAPTotal revenues

$
96,237$
-$
96,237$
2,530$
-$
2,530Cost of product sales

27,220(2,296)

(a)

24,9247,744(1,669)

(i)

6,075Selling, general and administrative


'/>"/>
SOURCE Jazz Pharmaceuticals plc
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Isis Pharmaceuticals Announces Proposed Public Offering of Common Stock
2. Alexza Pharmaceuticals to Present at Antiepileptic Drug and Device Trials (AED) XII Conference Highlighting Advances in the Treatment of Epilepsy
3. Kinex Pharmaceuticals and Zenith Technology Corporation announce the execution of a collaborative licensing agreement
4. Isis Pharmaceuticals Announces the Initiation of a Clinical Study of ISIS-STAT3 Rx in Patients with Liver Cancer
5. AcelRx Pharmaceuticals to Hold First Quarter 2013 Financial Results Conference Call and Webcast on May 8, 2013
6. Valeant Pharmaceuticals Provides Efinconazole Update
7. Arena Pharmaceuticals Provides Corporate Update and Reports First Quarter 2013 Financial Results
8. Cumberland Pharmaceuticals Reports First Quarter Financial Results
9. OncoGenex Pharmaceuticals, Inc. Provides Clinical Development Program Overview and Reports Financial Results for First Quarter 2013
10. Webcast Alert: Isis Pharmaceuticals First Quarter 2013 Financial Results Conference Call
11. Optimer Pharmaceuticals to Host Conference Call and Webcast to Discuss First Quarter 2013 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... Calif. , July 30, 2015  NanoSmart ... drug delivery platforms, has received Orphan Drug Designation ... a second drug product that uses NanoSmart,s proprietary ... formulation of dactinomycin for the treatment of Ewing,s ... The FDA granted NanoSmart,s Orphan Drug Designation on ...
(Date:7/30/2015)...  Cleave Biosciences today announced that the United ... company a key patent providing the protection of ... This newly issued patent, "Fused pyrimidines and ... allows for claims on the composition of matter ... of p97, a critical enzyme that controls various ...
(Date:7/30/2015)...  Alimera Sciences, Inc. (NASDAQ: ALIM ) (Alimera), ... and commercialization of prescription ophthalmic pharmaceuticals, today announced that ... financial results after the market close on Monday, August ... the same day at 4:30 p.m. ET. ... Officer, and Rick Eiswirth , Chief Operating Officer ...
Breaking Medicine Technology:NanoSmart Receives Second FDA Orphan Drug Designation for Treatment of Pediatric Cancer 2Alimera Sciences To Release Second Quarter Fiscal Year 2015 Financial Results 2
... , MOUNTAIN VIEW, Calif., Dec. 18 ... of Ruediger Naumann-Etienne to its Board of Directors. , "Rudi ... medical device companies," said Theodore A. Boutacoff, President and CEO ... & Quist followed by CEO/President positions with Diasonics, OEC Medical ...
... Dec. 18 Eli Lilly and Company (NYSE: ... and chief financial officer for Lilly, has assumed expanded responsibilities ... and chief financial officer, effective January 1. , In ... officer of the company and add responsibility for global services, ...
Cached Medicine Technology:Ruediger Naumann-Etienne Appointed to IRIDEX Board of Directors 2Ruediger Naumann-Etienne Appointed to IRIDEX Board of Directors 3Lilly CFO Derica Rice Assumes Expanded Responsibilities, Promoted to Executive Vice President 2
(Date:7/30/2015)... ... 30, 2015 , ... Boston Web Marketing is ... Google Partners is the platform for search marketing agencies to communicate with the ... necessary to run successful search marketing campaigns. Google Partners also affords businesses the ...
(Date:7/30/2015)... ... July 30, 2015 , ... Ocean Hills Recovery has officially been accredited ... “no recommendations.” No recommendations means CARF found no areas in the OHR program that ... than 3% of all facilities receive. In addition, Ocean Hills was granted the maximum ...
(Date:7/30/2015)... ... July 30, 2015 , ... ... National Cancer Institute Designation , The Tisch Cancer Institute (TCI) at the Icahn ... (NCI)-designated cancer center. TCI joins an elite group of 69 cancer institutions nationwide ...
(Date:7/30/2015)... ... 30, 2015 , ... 1Heart Caregiver Services LLC is offering its 1st Business ... in the Booming Homecare Business.” This will be held in its main headquarters at ... event will be hosted by 1Heart’s very own Randy Clarito (Director of Business and ...
(Date:7/30/2015)... (PRWEB) , ... July 30, 2015 , ... Summer is ... hot spots.”* Add to that a particularly long, dry and hot 2015 summer season ... host and fresh water advocate Sharon Kleyne will discuss the 2015 summer season and ...
Breaking Medicine News(10 mins):Health News:Boston Web Marketing Attends Google Partners All-Stars Summit 2Health News:Ocean Hills Recovery Receives Accreditation from CARF International 2Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 2Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 3Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 4Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 5Health News:The Tisch Cancer Institute at Icahn School of Medicine at Mount Sinai Earns National Cancer Institute Designation 6Health News:Upcoming Business Seminar at 1Heart Caregiver Services Headquarters Los Angeles California 2Health News:Fresh Water Advocate Sharon Kleyne Warns to Be Extra Cautious About Dry Eye “Hot Spot” Cities In Hot Dry Summer of 2015 2Health News:Fresh Water Advocate Sharon Kleyne Warns to Be Extra Cautious About Dry Eye “Hot Spot” Cities In Hot Dry Summer of 2015 3
... at the Medical Research Council have identified changes in ... in the esophagus, a condition called Barrett,s dysplasia, making ... before they develop into esophageal cancer. These findings, reported ... implications for patients and may help to monitor their ...
... new technology developed by neuroscientists at Cold Spring Harbor Laboratory ... made of whole brains. Until now, means of obtaining ... mammalian brain -- have been painstakingly slow and available only ... By automating and standardizing the process in which brain samples ...
... (HealthDay News) -- When women seem scarce, men may compete ... according to a new study. "What we see in ... more competitive. They compete more for access to mates," lead ... Carlson School of Management at the University of Minnesota, said ...
... FRIDAY, Jan. 13 (HealthDay News) -- Health and fitness experts ... by flogging long-range benefits such as losing weight or avoiding ... been going about it all wrong. Research now appears to ... effective message than "feel better now." A University of ...
... indices to identify patients with symptoms associated with ovarian cancer who ... the US in an attempt to promote earlier diagnosis, but they ... cancer, according to a study published January 13 in the ... cancer is a disease which is perceived to rarely produce symptoms ...
... wearing contact lenses affects glaucoma measurements has been named ... of Medicine,s annual St. Albert,s Day research symposium. ... fourth-year student at Stritch School of Medicine. Brenner ... on retinal nerve fiber layer measurements, which ophthalmologists use ...
Cached Medicine News:Health News:Researchers use sugar to halt esophageal cancer in its tracks 2Health News:CSHL team introduces automated imaging to greatly speed whole-brain mapping efforts 2Health News:CSHL team introduces automated imaging to greatly speed whole-brain mapping efforts 3Health News:Do Men Flash Cash to Find a Mate? 2Health News:Need to Exercise More? Think How It Will Help You Now 2Health News:Need to Exercise More? Think How It Will Help You Now 3Health News:Predicting the value of indexing symptoms for ovarian cancer 2
... Eliminate the need for makeshift, modified ... Why waste time gathering parts when your ... need to deliver the utmost in Heliox ... therapy is fast becoming the standard of ...
... has been developing diverse medical ... years. Our medical-surgical products have ... innovation, quality and customer satisfaction. ... the Labtron® line of diagnostic ...
... nebulizer utilizing Vibrating Mesh Technology to ... suffering from Asthma, COPD or other ... product size and handy carrying case ... takes them. Powerful delivery comparable to ...
... deliver particulate humidity in the 3 to ... patients. For your convenience, Thera-Mist® nebulizers may ... sterile water., ,The P30000N, for normal ... with a total flow range of 68-24 ...
Medicine Products: